Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Alaunos Therapeutics, Inc. (TCRT) had Income from Continuous Operations of $-0.89M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.00M |
|
$-0.89M |
|
-- |
|
$0.00M |
|
$0.91M |
|
$-0.91M |
|
$0.01M |
|
$-0.89M |
|
$-0.89M |
|
$-0.89M |
|
|
Income from Continuous Operations |
$-0.89M |
$-0.89M |
|
$-0.89M |
|
$-0.91M |
|
$-0.91M |
|
1.95M |
|
1.95M |
|
$4.60 |
|
$4.60 |
|
| Balance Sheet Financials | |
$1.99M |
|
$0.09M |
|
$0.98M |
|
$2.97M |
|
$0.81M |
|
-- |
|
-- |
|
$0.81M |
|
$2.15M |
|
$2.15M |
|
$2.15M |
|
2.35M |
|
| Cash Flow Statement Financials | |
$-2.87M |
|
$-0.10M |
|
$3.26M |
|
$1.09M |
|
$1.39M |
|
$0.29M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-30233.33% |
|
-30233.33% |
|
-- |
|
-29766.68% |
|
-29766.68% |
|
$-2.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.00 |
|
90.00 |
|
-41.48% |
|
-41.48% |
|
-30.11% |
|
-41.48% |
|
$0.92 |
|
$-1.52 |
|
$-1.47 |
|